Predictors of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

Study of the Relation between Plasma PTX3 Levels and Preclinical Atherosclerotic Cardiovascular Complications in Type 2 Diabetic Patients

Study of the Relation between Plasma PTX3 Levels and Preclinical Atherosclerotic Cardiovascular Complications in Type 2 Diabetic Patients

Study of Plasma Copeptin as a Predictor of Diabetic Nephropathy in Type 2 Diabetic Patients

Serum calprotectin in patients with type 2 diabetes mellitus and its relation to microvascular complications.

Association between Growth Differentiation Factor 15 and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

Chemerin Novel Biomarker As a Prognostic Factor for Cardiovascular Complications in Type 2 Diabetic Patients

Role of Procalcitonin as a Prognostic Marker in Patients with Diabetic Ketoacidosis

The Utility of Serum Procalcitonin Level as an Early Diagnostic Biomarker for COVID in Patients Presenting with ST-Elevation Myocardial Infarction Post Primary Percutaneous Coron

High Sensitivity Cardiac Troponin T in Patients with Type 2 Diabetes Mellitus, Relation to Cardiac Metabolic Risk Factors: Hypertension and Truncal Obesity